GALIMBERTI STEFANIA

Robba, C., Graziano, F., Picetti, E., Åkerlund, C., Addis, A., Pastore, G., et al. (2024). Early systemic insults following traumatic brain injury: association with biomarker profiles, therapy for intracranial hypertension, and neurological outcomes-an analysis of CENTER-TBI data. INTENSIVE CARE MEDICINE, 50(3), 371-384 [10.1007/s00134-024-07324-8]. Detail

Galimberti, S., Petrosino, M., Rebora, P., Oddo, M., Taccone, F., Citerio, G. (2024). The predictive value and clinical use of the neurological pupillary index – Authors' reply. LANCET NEUROLOGY, 23(3 (March 2024)), 229-230 [10.1016/S1474-4422(23)00504-5]. Detail

Risca, G., Capitoli, G., Rotolo, F., Galimberti, S., Valsecchi, M. (2023). Validation of a skewed surrogate endpoint for a time-to-event outcome: the use of a Zaga distribution. Intervento presentato a: ISCB44, Milan, Italy. Detail

Biondi, M., Tettamanti, S., Galimberti, S., Cerina, B., Tomasoni, C., Dotti, G., et al. (2023). Overexpression of CXCR4 receptor on CD33.CAR-CIK cells enhances the control of the Acute Myeloid Leukemia burden. Intervento presentato a: 5th European CAR T-cell meeting, Virtual, online. Detail

Mauro, S., Bolognesi, M., Villa, N., Capitoli, G., Furia, L., Mascadri, F., et al. (2023). A DNA damage response-like phenotype defines a third of colon cancers at onset. THE FASEB JOURNAL, 37(7 (July 2023)), 1-13 [10.1096/fj.202300132R]. Detail